Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.10 USD
Change Today +0.10 / 1.67%
Volume 642.0
LLTP On Other Exchanges
As of 8:10 PM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

David Sinclair Ph.D.

Chief Science Officer, Lightlake Therapeutics Inc.
AgeTotal Calculated CompensationThis person is connected to 65 board members in 4 different organizations across 6 different industries.

See Board Relationships


Dr. David Sinclair, Ph.D. serves as the Chief Science Officer of Lightlake Therapeutics Inc. Dr. Sinclair is a Co-Founder of Genocea Biosciences, Inc. He is Founder of Cohbar, Inc. and serves as its Consultant. He served as a Venture Partner at Lux Capital Management since December 19, 2007. He Co-Founded Sirtris Pharmaceuticals, Inc. in 2004. In 1997, he identified the cause of aging in yeast, a first for any species, and in 2003 reported the discovery of a conserved ...

Read Full Background

Corporate Headquarters*

96-98 Baker Street
London, Greater London W1U 6TJ

United Kingdom

Phone: 44 20 3617 8739
Fax: 44 20 7034 1943

Board Members Memberships*

Director and Member of Strategic Advisory Board
Co-Founder, Director and Member of the Scientific Advisory Board
Member of The Board of Directors


Post-Doctoral Training
Massachusetts Institute of Technology
University Of New South Wales

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LLTP:US $6.10 USD +0.10


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LIGHTLAKE THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at